Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Eylea image

Eylea approval for wet AMD

November 29, 2012
Sales and Marketing Bayer, Eylea, Lucentis, Novartis, avastin, wet AMD

Bayer HealthCare’s Eylea has been appoved in Europe for the treatment of neovascular age-related macular degeneration (wet AMD). The eye …

News

Pharma manufacturing news in brief

November 20, 2012
Manufacturing and Production Alfa Laval, Boehringer, Fujifilm, Health Canada, Novartis

Our latest round-up of manufacturing news includes a facility contract for Alfa Laval, plus updates from Fujifilm, Novartis, Boehringer Ingelheim …

News

Novartis treatments set for approval

November 19, 2012
Sales and Marketing Bexsaro, CHMP, Novartis, exjade

Two Novartis drugs, meningococcal vaccine Bexsero and iron chelation therapy Exjade, have been given positive opinions by the CHMP, with …

News
Novartis image

Novartis says Canada and Switzerland lift vaccines ban

November 2, 2012
Manufacturing and Production Canada, Novartis, Switzerland, vaccines

A temporary suspension on the distribution of flu vaccines made by Novartis has been lifted in Canada and Switzerland. The …

News

Novartis to build $500 million biotech facility in Singapore

November 1, 2012
Manufacturing and Production, Sales and Marketing Jimenez, M&P, Novartis, Singapore

Novartis is overseeing the construction of a biotechnology facility in Singapore that is the result of a $500m investment injection. …

News

Canada latest country to suspend sales of Novartis vaccines

October 30, 2012
Manufacturing and Production Canada, Novartis, vaccines

Canada has said it will suspend sales of two flu vaccines made by Novartis – following in the footsteps of …

News
Novartis image

EU countries suspend sales of Novartis flu vaccines

October 29, 2012
Manufacturing and Production, Sales and Marketing EU, Novartis, vaccines

Contamination of Novartis flu vaccines with white particles has resulted in regulatory actions from various authorities in the EU, including …

News
Gilenya image

Novartis’ MS drug improves outcomes

October 15, 2012
Sales and Marketing MS, Novartis, gilenya

Novartis’ multiple sclerosis (MS) drug Gilenya has demonstrated what the manufacturer calls ‘significant’ benefits for patients if used early. Results …

News
Lucentis image

NICE does Lucentis U-turn

October 5, 2012
Sales and Marketing Lucentis, NICE, Novartis, Roche, avastin

NICE has done a U-turn over its previous verdict on Novartis’ Lucentis, now recommending the drug in draft guidance to …

News

Seebri Breezhaler approved in Europe

October 4, 2012
Sales and Marketing COPD, Novartis, Relvar, Seebri Breezhaler, Tudorza

Novartis has been given approval in Europe for its Seebri Breezhaler to be used as maintenance treatment for chronic obstructive …

News
Afinitor image

Afinitor’s new UK indication launched

September 20, 2012
Sales and Marketing Afinitor, CHMP, Novartis, breast cancer

Novartis’ cancer drug Afinitor has been made available in the UK for patients with the most common form of advanced …

News

Novartis to file for new Lucentis indication

September 7, 2012
Lucentis, Novartis, macular edema, macular oedema, ophthamology

Novartis is set to file eye treatment Lucentis for a new indication. The firm will submit Lucentis (ranibizumab) to the …

News
Novartis

Novartis cheered by COPD trial results

September 3, 2012
Research and Development COPD, ERS, Novartis

One of Novartis’ experimental respiratory drugs has proved superior in a late-stage trial to Boehringer Ingelheim and Pfizer’s existing brand …

News

Novartis’ myelofibrosis treatment approved in Europe

August 28, 2012
Sales and Marketing Incyte, Jakavi, Novartis, Orphan Drugs, myelofibrosis

Novartis’ Jakavi, a new treatment for patients with myelofibrosis has been approved in Europe. The drug was co-developed with Incyte, …

News
Novartis image

Novartis’ Indian patent case delayed

August 23, 2012
Sales and Marketing Glivec, MSF, Novartis, generics

Novartis’ court case against the Indian government has been put on hold until next month. The case was suppose to …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025